STIGALL L. JEREMY (CIK 1929859) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy CLPT (1,781 shares), Buy CLPT (30,995 shares), Sell CLPT (15,151 shares), Buy CLPT (8,291 shares), Sell CLPT (3,224 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 1,781 | $21,247 |
| 2026-03-16 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 30,995 | $0 |
| 2026-03-16 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Sell | 15,151 | $174,691 |
| 2026-03-13 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 8,291 | $0 |
| 2026-03-13 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Sell | 3,224 | $37,463 |
| 2026-03-10 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 17,778 | $0 |
| 2026-03-10 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Sell | 6,913 | $69,130 |
| 2026-03-05 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 8,856 | $0 |
| 2026-03-05 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Sell | 4,506 | $39,833 |
| 2026-01-05 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 1 | $10 |
| 2025-07-02 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Buy | 1,608 | $16,321 |
| 2025-06-12 | ClearPoint Neuro, Inc. (CLPT) | Chief Business Officer | Sell | 3,561 | $47,326 |
来源：SEC Form 4 申报文件 · 截至 2026-07-02